Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.
Immunotherapies for various neurodegenerative diseases have recently emerged as a promising approach for clearing pathological protein conformers in these disorders. This type of treatment has not been assessed in models that develop neuronal tau aggregates as observed in frontotemporal dementia and Alzheimer's disease. Here, we present that active immunization with a phosphorylated tau epitope, in P301L tangle model mice, reduces aggregated tau in the brain and slows progression of the tangle-related behavioral phenotype. Females had more tau pathology than males but were also more receptive to the immunotherapy. The tau antibodies generated in these animals recognized pathological tau on brain sections. Performance on behavioral assays that require extensive motor coordination correlated with tau pathology in corresponding brain areas, and antibody levels against the immunogen correlated inversely with tau pathology. Interestingly, age-dependent autoantibodies that recognized recombinant tau protein but not the immunogen were detected in the P301L mice. To confirm that anti-tau antibodies could enter the brain and bind to pathological tau, FITC-tagged antibodies purified from a P301L mouse, with a high antibody titer against the immunogen, were injected into the carotid artery of P301L mice. These antibodies were subsequently detected within the brain and colocalized with PHF1 and MC1 antibodies that recognize pathological tau. Currently, no treatment is available for clearing tau aggregates. Our present findings may lead to a novel therapy targeting one of the major hallmarks of Alzheimer's disease and frontotemporal dementia.
Asuni
Ayodeji A
AA
Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA.
Boutajangout
Allal
A
Quartermain
David
D
Sigurdsson
Einar M
EM
D000367:Age Factors; D000704:Analysis of Variance; D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D001522:Behavior, Animal; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D003704:Dementia / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007930:Leucine / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009447:Neuroblastoma; D011392:Proline / Q000235:genetics; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D021641:Recognition, Psychology / Q000187:drug effects / Q000502:physiology; D012737:Sex Factors; D016875:tau Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*
D000906:Antibodies; D016875:tau Proteins; D011392:Proline; D007930:Leucine
J Neurosci Res. 1999 Mar 15;55(6):713-23
10220112
Exp Neurol. 1999 May;157(1):211-21
10222124
Cell Mol Neurobiol. 2000 Apr;20(2):217-30
10696511
J Neurosci. 2000 Apr 15;20(8):2926-33
10751445
Nat Genet. 2000 Aug;25(4):402-5
10932182
J Biol Chem. 2001 Jan 5;276(1):529-34
11013246
Neurobiol Aging. 2000 Sep-Oct;21(5):719-27
11016541
J Biochem Biophys Methods. 2000 Nov 20;46(1-2):69-81
11086195
FEBS Lett. 2001 Mar 23;493(1):40-4
11278002
Am J Pathol. 2001 Aug;159(2):439-47
11485902
Neurobiol Dis. 2001 Aug;8(4):555-67
11493021
Science. 2001 Aug 24;293(5534):1487-91
11520987
Science. 2001 Aug 24;293(5534):1491-5
11520988
J Lab Clin Med. 1975 Nov;86(5):887-98
1185045
J Neurosci Res. 2002 Jul 1;69(1):110-6
12111822
Neurology. 2002 Aug 13;59(3):398-407
12177374
Nat Rev Neurosci. 2002 Oct;3(10):824-8
12360327
Peptides. 2002 Dec;23(12):2223-6
12535702
Nat Med. 2003 Apr;9(4):448-52
12640446
Magn Reson Med. 2003 Aug;50(2):293-302
12876705
J Biol Chem. 1992 Jan 5;267(1):564-9
1370450
FASEB J. 2004 Jan;18(1):182-4
14630707
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7252-6
1496020
Brain Pathol. 2004 Jan;14(1):11-20
14997933
Semin Cell Dev Biol. 2004 Feb;15(1):45-9
15036206
Thromb Haemost. 2004 Jun;91(6):1056-64
15175790
J Neurosci. 2004 Jul 14;24(28):6277-82
15254082
Curr Drug Targets. 2004 Aug;5(6):495-502
15270196
Neuron. 2004 Aug 5;43(3):321-32
15294141
J Neurosci Methods. 2004 Sep 30;138(1-2):233-42
15325132
J Pharmacol Exp Ther. 2005 Feb;312(2):659-68
15375176
J Pharm Sci. 2004 Nov;93(11):2645-68
15389672
J Biol Chem. 2005 Feb 4;280(5):3628-35
15525637
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):227-31
15615853
Neurology. 2005 Jan 11;64(1):129-31
15642916
Proc Natl Acad Sci U S A. 2005 May 10;102(19):6990-5
15867159
J Neurosci. 2005 Jun 1;25(22):5446-54
15930395
Neuron. 2005 Jun 16;46(6):857-68
15953415
Curr Alzheimer Res. 2005 Apr;2(2):231-8
15974923
Methods Mol Biol. 2005;299:299-308
15980613
Science. 2005 Jul 15;309(5733):476-81
16020737
Neurobiol Dis. 2005 Dec;20(3):814-22
16125396
Am J Pathol. 2006 May;168(5):1598-607
16651626
Curr Pharm Des. 2006;12(20):2569-85
16842179
Exp Neurol. 1990 Mar;107(3):263-70
1689666
Neurology. 1990 Mar;40(3 Pt 1):419-22
1690363
Eur J Neurosci. 2006 Nov;24(9):2530-42
17100841
Nat Cell Biol. 2007 Feb;9(2):139-48
17187063
Neurobiol Aging. 2008 Jun;29(6):836-47
17291630
J Biol Chem. 2007 Jun 29;282(26):18895-906
17468102
J Biol Chem. 1990 Dec 5;265(34):21355-62
2250029
Neurology. 1987 Nov;37(11):1780-4
2444904
Acta Neuropathol. 1989;78(1):16-21
2735186
J Neurol Sci. 1986 May;73(3):257-67
3522806
Immunology. 1970 Jun;18(6):875-81
4913804
J Neurosci Res. 1994 Dec 15;39(6):669-73
7534834
Cell. 1995 Jul 28;82(2):331-40
7543026
Neuroscience. 1994 Nov;63(1):95-122
7898665
Prog Brain Res. 1994;101:383-90
8029466
J Comp Neurol. 1994 Apr 22;342(4):481-96
8040362
Neuroscience. 1993 Sep;56(1):109-27
8232910
Exp Neurol. 1993 Apr;120(2):245-63
8491281
J Neurosci Res. 1997 Apr 15;48(2):128-32
9130141
J Neurosci. 1997 Aug 15;17(16):6142-51
9236226
Neurobiol Aging. 1996 Nov-Dec;17(6):893-901
9363801
Neurobiol Aging. 1997 Nov-Dec;18(6):591-608
9461057
Brain Pathol. 1998 Apr;8(2):387-402
9546295
Ann Neurol. 1998 Jun;43(6):815-25
9629852
J Immunol. 1998 Jul 15;161(2):692-701
9670944